This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Biointegrence Inc., Hiroshima Industrial Promotion Organization, Riken Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011
Title: Fuyuki Miya: Innovator in Hepatocyte Treatment
Introduction
Fuyuki Miya is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of liver diseases. His innovative approach has led to the development of a unique method for treating mice carrying human hepatocytes.
Latest Patents
Fuyuki Miya holds a patent for a method of treating mice that carry human hepatocytes. The patent describes a process where human adult hepatocytes are transplanted into an immunodeficient hepatopathy mouse. Following the transplantation, human growth hormone is administered to the mouse, which elevates the replacement ratio of the transplanted human adult hepatocytes. Additionally, the method improves fatty liver conditions in mice where a significant percentage of hepatocytes have been replaced by human hepatocytes.
Career Highlights
Throughout his career, Fuyuki Miya has worked with prominent companies in the biotechnology sector. He has been associated with Biointegrence Inc. and Riken Corporation, where he has contributed to various research initiatives and advancements in medical treatments.
Collaborations
Fuyuki Miya has collaborated with several professionals in his field. Notable coworkers include Norio Masumoto and Miho Kataoka, who have worked alongside him on various projects related to hepatocyte research.
Conclusion
Fuyuki Miya's innovative work in the treatment of liver diseases showcases his dedication to advancing medical science. His patented method represents a significant step forward in the field of hepatocyte treatment, highlighting the importance of collaboration and research in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile